期刊文献+

糖皮质激素鼻喷雾剂联合地氯雷他定治疗过敏性鼻炎的效果 被引量:3

Effect of Glucocorticoid Nasal Spray Combined with Desloratadine in the Treatment of Allergic Rhinitis
原文传递
导出
摘要 目的:探讨糖皮质激素鼻喷雾剂治疗过敏性鼻炎(AR)的临床疗效。方法:选取2020年5月—2022年5月本院就诊的AR患者160例作为研究对象,按照随机数字表法将其分为观察组(n=80)和对照组(n=80)。对照组采取地氯雷他定进行治疗,观察组则在对照组基础上联合糖皮质激素鼻喷雾剂治疗,比较两组临床疗效、炎症因子[白介素-6(IL-6)、白介素-10(IL-10)、肿瘤坏死因子α(TNF-α)]及预后情况(并发症发生率及复发率)。结果:观察组治疗总有效率为93.75%,高于对照组的83.75%(P<0.05);治疗后,观察组IL-6、TNF-α水平低于对照组,IL-10水平高于对照组(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05);随访3个月后,观察组复发率低于对照组(P<0.05)。结论:AR患者采取糖皮质激素鼻喷雾剂联合治疗方案的效果较好,可缓解患者临床症状,降低机体炎性因子水平,提升其治疗效果,值得临床应用。 Objective: To investigate the clinical efficacy of glucocorticoid nasal spray in the treatment of allergic rhinitis(AR). Methods: A total of 160 AR patients who were treated in our hospital from May 2020 to May 2022 were selected as the research objects. They were divided into observation group(n=80) and control group(n=80) according to the random number table method. The control group was treated with desloratadine, while the observation group was treated with glucocorticoid nasal spray on the basis of the control group. The clinical efficacy, inflammatory factors [interleukin-6(IL-6), interleukin-10(IL-10), tumor necrosis factor-α(TNF-α)] and prognosis(complication rate and recurrence rate) were compared between the two groups. Results: The total effective rate in observation group was 93.75%, which was higher than 83.75% in control group(P<0.05). After treatment, the levels of IL-6 and TNF-α in the observation group were lower than those in the control group, and the level of IL-10 was higher than that in the control group(P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05). After 3 months of follow-up, the recurrence rate of the observation group was lower than that of the control group(P<0.05).Conclusion: The combined treatment of glucocorticoid nasal spray in AR patients has a good effect, which can alleviate the clinical symptoms of patients, reduce the level of inflammatory factors in the body, and improve the therapeutic effect. It is worthy of clinical application.
作者 杨翠娥 涂海螺 石铁钢 YANG Cui'e;TU Hailuo;SHI Tiegang(Department of Otolaryngology,the Second Hospital of Integrated Traditional Chinese and Western Medicine,Nanchang 330006,Jiangxi,China;Department of Otolaryngology,Xinjian District People's Hospital,Nanchang 330199,Jiangxi,China;Department of Otology,Boda Otolaryngology Hospital,Jiangxi Academy of Medical Sciences,Nanchang 330001,Jiangxi,China)
出处 《中国药物滥用防治杂志》 CAS 2022年第12期1848-1850,1858,共4页 Chinese Journal of Drug Abuse Prevention and Treatment
关键词 过敏性鼻炎 糖皮质激素鼻喷雾剂 地氯雷他定 Allergic rhinitis Glucocorticoid nasal spray Desloratadine
  • 相关文献

参考文献7

二级参考文献239

  • 1沈朝斌,顾珺,林千里,戴强,陈卫平,吕红,舒志军.玉屏风散与T细胞亚型表达的Meta分析[J].上海中医药杂志,2004,38(11):59-61. 被引量:18
  • 2赵宇,C.Andrew van Hasselt,吴港生,黄约爱,梁传余,梁秉中.人肥大细胞系白细胞介素4的产生及药物对其的影响[J].中华耳鼻咽喉头颈外科杂志,2005,40(2):124-127. 被引量:3
  • 3顾之燕,董震.变应性鼻炎的诊治原则和推荐方案(2004年,兰州)[J].中华耳鼻咽喉头颈外科杂志,2005,40(3):166-167. 被引量:1708
  • 4韩德民,张罗,黄丹,武阳丰,董震,许庚,孔维佳,暴继敏,周兵,汪审清,王德辉,王秋萍.我国11个城市变应性鼻炎自报患病率调查[J].中华耳鼻咽喉头颈外科杂志,2007,42(5):378-384. 被引量:402
  • 5Bachert C, van Cauwenberge P. Desloratadine treatment for interrnittent and persistent allergic rhinitis: a review [J]. Clin Ther, 2007, 29 (9): 1795-1802.
  • 6Orzechowski RF, Currie DS, Valancius CA. Comparative anti-cholinergic activities of 10 histamine HI receptor antagonists in two functional models [J]. Eur J Pharmacol, 2005, 506 (3): 257- 264.
  • 7Pradalier A, Neukirch C, Dreyfus I, et al. Desloratadine im proves quality of life and symptom severity in patients with allergic rhinitis [J]. Allergy, 2007, 62 (11): 1331- 1334.
  • 8Ortonne JP, Grob JJ, Auquier P, et al. Efficacy and safety of Desloratadine in adults with chronic idiopathic urticaria: a randomized, double-blind, placebo controlled, multicenter trial [J]. AmJ ClinDermatoh 2007, 8 (1): 37-42.
  • 9Gillman S, Gillard M, Benedetti M. The concept of receptor occupancy to predict clinical efficacy: A comparison of second generation H1 antihistamines [J].Allergy Asthma Proc, 2009, 30 (10): 350-354.
  • 10Devillier P, Roche N, Faisy C. Clinical pharmacokinetics and pharmacodynamics of Desloratadine, fexofenadine and levocetirizine : a comparative review[J]. Clin Pharmacokinet, 2008, 47 (4): 217- 230.

共引文献1437

同被引文献38

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部